Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Handok Inc. clinical trials
The registry lists 46 studies whose lead sponsor is Handok Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 5, 2026.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Handok Inc..
- Handok Inc.46 studiesSame company
Something wrong?
Focus areas
Conditions Handok Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 46 of 46.
- Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedNCT07102719Phase 1
- Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedNCT06889350Phase 1
- Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedNCT06339788Phase 1
- A Retrospective Non-Interventional Study to Evaluate the Impact of Eculizumab in Korean PNH PatientsCompletedNCT05337683
- Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and MetforminCompletedNCT05504226Phase 3
- Observational of PNH Type Cells in Korean Patients With Bone Marrow Failure Syndrome and Having Hemolytic PNHCompletedNCT03460301
- Observational Study to Evaluate the Efficacy and Safety of TeneligliptinCompletedNCT03793023
- Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)CompletedNCT02512523Phase 4
- Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure (Teveten_MS)CompletedNCT02024100
- A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in aHUS Patients in South KoreaCompletedNCT05405777
- A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor PatientsTerminatedNCT04492033Phase 1/2
- Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and MetforminCompletedNCT05504239Phase 3
- Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy VolunteersCompletedNCT05663073Phase 1
- Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension PatientsCompletedNCT05475665Phase 3
- Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy VolunteersCompletedNCT05688085Phase 1
- Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension PatientsCompletedNCT05476354Phase 3
- Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy VolunteersCompletedNCT05688098Phase 1
- Tenelia Elderly CGMS Study(TEDDY)CompletedNCT03508323Phase 4
- Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential HypetensionCompletedNCT04488978Phase 2
- Pharmacokinetic Drug Interaction Between Teneligliptin and EmpagliflozinCompletedNCT04431141Phase 1
- A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ MalignanciesCompletedNCT04014257Phase 1
- A Study to Assess Efficacy and Safety of the Ketoprofen vs DiclofenacCompletedNCT04421911Phase 3
- Theracurmin vs Curcumin Bioavailability StudyCompletedNCT04028739Not applicable
- Teneligliptin and Atorvastatin DDI StudyCompletedNCT03769870Phase 1
- Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two PatientsCompletedNCT03011177Phase 4
- A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate DrugsCompletedNCT03787017Phase 1
- A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mgCompletedNCT03787043Phase 1
- Tenelia Triple Combination StudyCompletedNCT02567994Phase 3
- Teneligliptin-Glimepiride DDI StudyCompletedNCT03009513Phase 1
- HL2351 CAPS Phase II StudyTerminatedNCT02853084Phase 2
- Teneligliptin(MP-513) vs. Placebo in Patient With Metformin MonotherapyCompletedNCT01805830Phase 3
- A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation StudyCompletedNCT02175056Phase 1
- Observational Study to Investigate Resistant Hypertension Prevalence in Korean General HospitalsCompletedNCT01753206
- Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes MellitusCompletedNCT01798238Phase 3
- Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DMCompletedNCT00612144Phase 4
- Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes MellitusCompletedNCT00913367Phase 4
- Omnaris Versus Levocetirizine Phase 4 StudyCompletedNCT01430260Phase 4
- Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes MellitusCompletedNCT00975065Phase 4
- Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination TherapyCompletedNCT01444248Phase 4
- Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real PracticeCompletedNCT01438255
- Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)CompletedNCT01373398Phase 1
- Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mgCompletedNCT00934323Phase 1
- Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mgCompletedNCT00934817Phase 1
- Male Sexual Health Questionnaire (MSHQ) - Sexual Function StudyCompletedNCT00427882Phase 4
- Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)CompletedNCT00437554Phase 3
- Fexofenadine in Pruritic Skin DiseaseCompletedNCT00261079Phase 4